My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1771

    1.

    Assessment of hepatic insulin action in obese type 2 diabetic patients.

    Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.

    Diabetes. 2001 Jun;50(6):1363-70.PMID: 11375337 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.

    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.

    J Clin Endocrinol Metab. 1995 Aug;80(8):2464-9.PMID: 7629243 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.

    Lewis GF, Vranic M, Harley P, Giacca A.

    Diabetes. 1997 Jul;46(7):1111-9.PMID: 9200644 [PubMed - indexed for MEDLINE]Related articles

    5.

    Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    Cusi K, Consoli A, DeFronzo RA.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

    6.

    Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

    Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.

    Diabetes Care. 1995 May;18(5):666-73.PMID: 8586004 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

    Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.

    Båvenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S.

    J Clin Endocrinol Metab. 2003 Jan;88(1):82-7. Erratum in: J Clin Endocrinol Metab. 2003 May;88(5):2036. PMID: 12519834 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

    Meneilly GS, Elliott T.

    Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?

    Staehr P, Hojlund K, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabet Med. 2003 Oct;20(10):816-22.PMID: 14510862 [PubMed - indexed for MEDLINE]Related articles

    11.

    Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.

    Lewis GF, Carpentier A, Vranic M, Giacca A.

    Diabetes. 1999 Mar;48(3):570-6.PMID: 10078558 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes.

    Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, Hainault I, Vexiau P, Mauvais-Jarvis F, Calvo F, Gautier JF.

    Diabetes Care. 2008 Dec;31(12):2332-7. Epub 2008 Sep 22.PMID: 18809633 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.

    Koopmans SJ, Kushwaha RS, DeFronzo RA.

    Metabolism. 1999 Mar;48(3):330-7.PMID: 10094109 [PubMed - indexed for MEDLINE]Related articles

    15.

    In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.

    Bak JF, Møller N, Schmitz O, Saaek A, Pedersen O.

    Diabetologia. 1992 Aug;35(8):777-84.PMID: 1511806 [PubMed - indexed for MEDLINE]Related articles

    16.

    Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

    Diabetes. 2001 Aug;50(8):1844-50.PMID: 11473047 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hepatic insulin resistance after pancreas transplantation in type I diabetes.

    Rooney DP, Robertson RP.

    Diabetes. 1996 Feb;45(2):134-8.PMID: 8549855 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.

    Nagi DK, Tracy R, Pratley R.

    Metabolism. 1996 Oct;45(10):1243-7.PMID: 8843179 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

    Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA.

    Diabetes. 1999 Aug;48(8):1572-8.PMID: 10426375 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity